GlassScriptPhysician profile
Mark A Kazewych
NPI 1063452944
$11,382.24
in general payments reported to CMS, 2019-2025
24 companies · $1,056 in 2025
The $1,056 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,306 · 2020: $601 · 2021: $3,241 · 2022: $2,534 · 2023: $292 · 2024: $352 · 2025: $1,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,699.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $2,429.77 | 2021-2024 | Integrity |
| Stryker Corporation | $2,055.54 | 2019-2025 | Mako, Alphavent, Pangea |
| Advanced Orthopaedic Solutions, INC. | $1,911.33 | 2019 | |
| Pylant Medical | $1,464.10 | 2020-2025 | |
| Vericel Corporation | $765.98 | 2019-2025 | Maci |
| Horizon Therapeutics Plc | $547.47 | 2019-2022 | |
| Smith+Nephew, INC. | $495.10 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Novostitch, Acufex Meniscal Root Repair |
| Wright Medical Technology, INC. | $468.33 | 2019 | |
| Pacira Therapeutics, INC. | $391.28 | 2019-2021 | |
| Bone Support INC. | $192.26 | 2021 | |
| Linvatec Corporation | $149.39 | 2022-2023 | Biobrace 23mm |
| Carbofix Orthopedics INC | $136.18 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $71.51 | 2025 | Saw Guide |
| Depuy Synthes Sales INC. | $69.50 | 2020-2022 | |
| Microport Orthopedics INC | $41.00 | 2024 | Mpo Medial Pivot Knee |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $40.89 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Ebi, LLC | $40.89 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Bioventus LLC | $29.44 | 2025 | Exogen Ultrasound Bone Healing System |
| Zyla Life Sciences, INC. | $21.49 | 2019 | |
| Ferring Pharmaceuticals INC. | $20.78 | 2025 | Euflexxa |
| Cpm Medical Consultants, LLC | $18.05 | 2019 | |
| Molnlycke Health Care US, LLC | $11.29 | 2022 | |
| Heron Therapeutics, INC. | $10.67 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,635,256.15 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kazewych listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.